SCARFONE, GIOVANNA

SCARFONE, GIOVANNA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.006 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Carboplatin Alone vs Carboplatin plus Epidoxorubicin as Second-Line Therapy for Cisplatin- or Carboplatin-Sensitive Ovarian Cancer 1-apr-2001 G. BolisG. ScarfoneF. Parazzini + Article (author) -
Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study 1-giu-2014 G. ScarfoneS. NoliP. Vigano'M. CandianiF. Parazzini + Article (author) -
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 1-gen-2020 Fumagalli M.Fontana C.Mosca F.Passera S.Picciolini O.Scarfone G. + Article (author) -
Clear cell and papillary serous endometrial carcinomas : survival in a series of 128 cases 1-feb-2013 G. ScarfoneSECOMANDI, RITAF. ParazziniA. VillaE. RicciG. Bolis + Article (author) -
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol 1-gen-1998 G. ScarfoneG. Bolis + Article (author) -
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group 1-mar-2003 G. BolisG. Scarfone + Article (author) -
Effects of in-utero exposure to chemotherapy on fetal brain growth 1-set-2019 Passera S.Scarfone G.Fontana C.Cinnante C.Ossola M.Grossi E.Mosca F.Triulzi F.Fumagalli M. + Article (author) -
Epidemiology of breast cancer in young women 1-gen-2015 F. ParazziniG. PolverinoS. NoliG. Scarfone + Book Part (author) -
First Case Report of Pregnancy on Alectinib in a Woman With Metastatic ALK-Rearranged Lung Cancer: A Case Report 1-gen-2021 Scarfone G.Fumagalli M.Di Loreto E.Fontana C.Persico N.Zucchetti M. + Article (author) -
Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer–Adjuvant ChemoTherapy in Ovarian Neoplasm Trial 1-gen-2003 G. BolisG. Scarfone + Article (author) -
Long term survival of ovarian endometriosis associated clear cell and endometrioid ovarian cancers 1-feb-2013 S. NoliG. ScarfoneVILLA, ANTONELLA GIUSEPPINAE. MontiP. VercelliniF. Parazzini + Article (author) -
A multicenter, randomized, phase III study comparing paclitaxel/carboplatin (PC) versus topotecan/paclitaxe/carboplatin (TPC) in patients with stage III (residual tumor > 1 cm after primary surgery) and IV ovarian cancer (OC) 20-giu-2006 G. ScarfoneG. Bolis + Article (author) -
Obstetric and Neonatal Outcomes in Women with Pregnancy Associated Cancer: a population-based Study in Lombardy, Northern Italy 1-gen-2021 G. EspositoM. DalmartelloG. ScarfoneE. NegriF. ParazziniC. La Vecchia + Article (author) -
p53 Gene Status and Response to Platinum/Paclitaxel-Based Chemotherapy in Advanced Ovarian Carcinoma 1-dic-2000 G. BolisG. Scarfone + Article (author) -
Paclitaxel 175 or 225 mg per Meters Squared With Carboplatin in Advanced Ovarian Cancer: A Randomized Trial 1-feb-2004 G. BolisG. ScarfoneG. PolverinoF. Parazzini + Article (author) -
Paclitaxel vs Epidoxorubicin plus Paclitaxel as Second-Line Therapy for Platinum-Refractory and -Resistant Ovarian Cancer 1-gen-1999 G. BolisF. ParazziniG. Scarfone + Article (author) -
Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III–IV epithelial ovarian cancer a multicenter, randomized study 1-gen-2010 G. BolisG. Scarfone + Article (author) -
A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy 1-gen-1999 G. ScarfoneF. ParazziniC. SciattaG. PolverinoG. Bolis + Article (author) -
A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer 1-dic-2001 G. BolisG. ScarfoneSCIATTA, CESARINAG.P. PolverinoROSA, CRISTINAF. Parazzini + Article (author) -
Phase II Trial of Topotecan, Carboplatin, and Paclitaxel as Front-Line Therapy in Suboptimal Advanced Epithelial Ovarian Cancer 1-mag-2001 G. BolisG. ScarfoneF. Parazzini + Article (author) -